BillionToOne

Account Sales Representative (ASR)

Remote

Not SpecifiedCompensation
Entry Level & New GradExperience Level
Full TimeJob Type
UnknownVisa
Medical Devices, Biotechnology, DiagnosticsIndustries

Requirements

Candidates should possess a Bachelor's degree and at least 2 years of experience in sales, with a strong understanding of the molecular diagnostics industry preferred. Excellent communication and interpersonal skills are essential, along with the ability to work independently and as part of a team. Familiarity with sales processes and CRM software is beneficial.

Responsibilities

The Account Sales Representative will provide regional assistance by supporting the daily needs of the sales team across the assigned territory, maintain and strengthen relationships with existing clients, provide coverage in open territories to ensure continuity of service and sales activity, and assist field sales representatives with account management and growth.

Skills

Customer Support
Account Management
Sales Support
Territory Coverage
Relationship Building
Administrative Support
Logistical Support
Sales Forecasting

BillionToOne

Molecular diagnostics for prenatal and oncology testing

About BillionToOne

BillionToOne specializes in molecular diagnostics within the healthcare sector, focusing on prenatal screening and oncology testing. Their proprietary QCT technology allows for the detection and quantification of diseases at a single base-pair resolution, enabling the identification of minute variations in DNA. The company offers two main products: Northstar Select™, which helps determine the best initial therapy for patients, and Northstar Response™, which tracks the effectiveness of that therapy. Unlike many competitors, BillionToOne emphasizes accuracy, efficiency, and accessibility in molecular testing, providing diagnostic services directly to healthcare providers. Their goal is to positively impact healthcare by making molecular testing more reliable and available to everyone.

Key Metrics

Menlo Park, CaliforniaHeadquarters
2016Year Founded
$380.2MTotal Funding
SERIES_DCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees

Benefits

Competitive pay
Retirement savings package
Parental leave
Free snacks & lunches
Medical, dental, & vision premiums
On campus perks
Free-on-site EV charging

Risks

Emerging biotech startups could threaten BillionToOne's market share.
Rapid technological advancements may render their current technology obsolete.
Expansion into new facilities may face operational challenges or delays.

Differentiation

BillionToOne's QCT technology detects DNA variations at single base-pair resolution.
Their UNITY Fetal Antigen NIPT is the first US cfDNA test for fetal antigen genotyping.
They replace invasive amniocentesis with a safe, affordable blood test for prenatal screening.

Upsides

BillionToOne achieved a billion-dollar valuation with a $130 million funding round.
Their new Austin facility will create 1,000 jobs, boosting production and local economy.
Recognition as Diagnostics Company of the Year highlights their industry leadership.

Land your dream remote job 3x faster with AI